Assembly Biosciences, Inc.
ASMB
$30.82
$0.411.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 293.63% | 12.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 293.63% | 12.08% | |||
| Cost of Revenue | 4.00% | 2.87% | |||
| Gross Profit | 534.96% | 10.79% | |||
| SG&A Expenses | 6.59% | 10.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.61% | 4.60% | |||
| Operating Income | 281.93% | 1.89% | |||
| Income Before Tax | 340.21% | 9.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 340.21% | 9.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 340.21% | 9.83% | |||
| EBIT | 281.93% | 1.89% | |||
| EBITDA | 282.76% | 1.90% | |||
| EPS Basic | 279.90% | 45.58% | |||
| Normalized Basic EPS | 279.89% | 45.57% | |||
| EPS Diluted | 279.90% | 45.58% | |||
| Normalized Diluted EPS | 279.89% | 45.57% | |||
| Average Basic Shares Outstanding | 33.52% | 65.70% | |||
| Average Diluted Shares Outstanding | 33.52% | 65.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||